glp-1 tx How medications are transforming diabetes and weight loss treatment GLP-1 medication changes may support

I think it's also really important to clarify, having a history of thyroid cancer is not an [00:40:00] exclusion criteria of these medications, unless again, it's a medullary thyroid carcinoma

Eli Lilly is now armed on the GLP-1 front in both diabetes and weight loss as its finally received US Food and Drug Administration (FDA) approval for Zepbound (tirzepatide), the obesity version of diabetes sensation Mounjaro (tirzepatide)

Asuquo ME, Ebughe G

Regulatory and safety status: It is currently awaiting FDA review

Another important difference lies in the interpretation of risk and benefit

Produced in a GMP-certified facility to ensure purity and quality